Navigation Links
Frost & Sullivan Honors ConforMIS for Its Contribution to Personalized Care Through its Customized Implant Development Technologies
Date:8/18/2008

PALO ALTO, Calif., Aug. 18 /PRNewswire/ -- Based on its recent analysis of the personalized healthcare market, Frost & Sullivan presents ConforMIS with the 2008 North American Frost & Sullivan Award for Medical Device Healthcare Innovation. This recognition is in support of the company's unique commitment to delivering orthopedic implants that precisely fit each individual unlike traditional implants that require surgeons to shape patients' bones to fit standardized implants.

"The field of orthopedic implants is poised to transition towards personalized implants since off-the-shelf implant designs cannot accommodate all of the anatomic variations present across patients," explains Frost & Sullivan Research Analyst Archana Swathy. "ConforMIS is a pioneer, fueling this transition through the company's revolutionary technology platforms -- the iFit(TM) technology and iJig(TM) instrumentation."

While traditional orthopedic implants have undergone a long continuum of scaled developments to reach a certain level of sophistication, ConforMIS aims to revolutionize the very approach to implants through customization. Surgeries involving ConforMIS implants are minimally invasive, removing minimal bone and cartilage. This radical patient-specific initiative employs the proprietary "image-to-implant" technology platforms. The iFit technology transforms CT and MR imaging data into implants that are made to precisely fit the topography of the damaged joint. The same imaging data is utilized to create the iJig instrumentation, which are disposable patient-specific cutting and placement guides that help simplify the surgical process and improve surgical outcomes and efficiency.

The image-to-implant technology platforms ensure optimal implant fit and alignment, while offering complete coverage of weight-bearing surfaces. ConforMIS implants also offer thorough coverage of the cortical rim on the tibia, which minimizes the risk of subsidence and loosening,
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
2. Direct From Beijing, 2008 Olympic Gymnastic Superstars and Grammy Award Winning Icons Descend Upon San Diego to Tape ABC Network Womens Cancer Awareness Special, Frosted Pink With A Twist
3. Kingfisher Healthcare (KFH) Wins Prestigious Frost & Sullivan Best Practices Award
4. Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy
5. Draeger Receives Frost & Sullivan Consumer Award for Respiratory Protection
6. Therapy Could Save Limbs After Frostbite
7. Help Your Kids Earn an A for Attentiveness with a Bowl of Frosted Mini- Wheats(R) Cereal for Breakfast
8. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
9. Nancy Frost Joins Lawson-Hawks as Employee Benefits Vice President
10. MedApps Receives Prestigious Frost & Sullivan Award
11. Kelloggs Frosted Flakes Gold(TM) Helps Moms Get the Gold

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...finds gene variation believed to affect circadian ...Day News) -- New research suggests that an interna...tor in the development of bipolar disorder in chil...on of the genetic makeup of 152 children with bipo... major mood swings, and 140 children without the d...
(Date:11/27/2009)... , DALLAS, Nov. 27 C... procedure only 25 years ago, solid organ transpla...thanks to the extraordinary men and women who gath... 11. Leaders came together from medical centers ar...f Baylor Regional Transplant Institute (BRTI), one...
(Date:11/27/2009)... XenaCare Holdings has announce...hritis Foundation, one of the largest nonprofit or...blic health education. , ...Care Holdings, Inc. (OTCBB: XCHO), a company speci...f consumer healthcare products, has announced toda...
(Date:11/27/2009)... Multi-purpose bilingual colori...ned for use by the business community to educate -... subjects from Safety issues to Dinosuars to ABC,S... Saint Louis, MO (PRWEB) November 27, 2009 --...ronics or toys to keep them busy any hour of the d...
(Date:11/26/2009)...he next 25 years, the number of Americans living w...3.7 million in 2009 to 44.1 million in 2034. Over ...triple, rising from $113 billion to $336 billion, ..., researchers based at the University of Chicago r... The number of those with diabetes covered by Med...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...er a defeat, and dropped after a victory , ... your favorite NFL team lose in the Super Bowl cou... However, the good news is that a victory might do... To come to this conclusion, a team from the Keck ...
... has quickly evolved into a historic Midwest disas...ider in Northwestern Minnesota and Eastern North D...e in the region. Despite rising flood waters and d...n with the public, Innovis Health has enlisted inn...
...disorders , , SATURDAY, March 28 (HealthDa...a one-time bellyache, but it also could be a sign ...nd, chief of gastroenterology at Baylor University... persistent symptoms, such as abdominal pain or di...
...nd dynamic course format in Lymphedema Therapy Cer...L (PRWEB) March 28, 2009 -- The Academy of Lymphat...ining in the United States in the early 90,s using...emy of Lymphatic Studies changed its traditional t...
...man Pheromone Sciences, Inc. (OTC Bulletin Board: ...ults for the three months and the year ended Decem...31, 2008, net revenue was $228,000, representing a...e of $38,000 ($0.01 per share) for the same period...
...itution of $2.3 billion and forfeit $1.7 billion ,...ury Financial Enterprises (NCFE) executives were s...ive investors about the financial health of NCFE, ...d in Dublin, Ohio, was one of the largest healthca...
Other Medicine News:Health News:Super Bowl Loss Can 'Kill' Some Fans 2Health News:Innovis Health Continues to Serve Region 2Health News:What You Need to Know When Your Stomach Aches 2Health News:Academy of Lymphatic Studies Announces Accelerated Hybrid Online Program 2Health News:Human Pheromone Sciences Announces Fourth Quarter and Full Year Results 2Health News:Human Pheromone Sciences Announces Fourth Quarter and Full Year Results 3Health News:Human Pheromone Sciences Announces Fourth Quarter and Full Year Results 4Health News:Human Pheromone Sciences Announces Fourth Quarter and Full Year Results 5Health News:Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering 2Health News:Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering 3Health News:Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering 4
(Date:11/25/2009)...., Nov. 25 Pharmasset, I...cal company committed to discovering, developing a...ctions, reported financial results for the fiscal ...09 Pharmasset held $58.4 million in cash, cash equ...ine Update and 2009 Highlights ,, RG7128 ,...
(Date:11/25/2009)...., Nov. 25 The FDA granted traditi...lets, a non-nucleoside reverse transcriptase inhib...ally indicated for use in treatment-experienced ad...IV-1 strains resistant to an NNRTI and other antir...is based on 48-week data from two Phase 3 studies ...
(Date:11/25/2009)... N.J., Nov. 25 Regado Biosciences,...of antithrombotic aptamers with active control age...ident, will be presenting at the Piper Jaffray 21s...lace Hotel in New York City. Dr. Mazzo,s presenta...ember 1 and will include an overview of the Compan...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Neuronal survival and axonal regrowth obtained in vitro 52676 1Neuronal survival and axonal regrowth obtained in vitro 52676 2Limited data suggest possible association between Agent Orange exposure 52674 1Limited data suggest possible association between Agent Orange exposure 52674 2Limited data suggest possible association between Agent Orange exposure 52674 3Pinpointing cause of colic 3A UT Houston researchers identify organism 52672 1Pinpointing cause of colic 3A UT Houston researchers identify organism 52672 2
...Newswire-FirstCall/ - Alfacell Corporation,(Nasdaq...n the International,Journal of Oncology (2007; Vol...ubstantially decreases reactive oxygen intermediat.... The observed antioxidant activity,of ONCONASE ma...ells and,mechanistic synergism with other anti-can...
...ngle, Higher, More Concentrated Dose of ...f., Aug. 22 Nuvelo, Inc.,(Nasdaq: NUVO ) today a...NOMA-3 (Speedy Opening of Non-functional and Occlu...evaluating lead product candidate,alfimeprase, for...n (CO). This open-label, single-arm trial will ev...
Other Medicine Technology:Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 2Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 3Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion 2Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion 3Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion 4
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: